Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Citi
Queensland Health
McKesson
Cantor Fitzgerald
Accenture
Harvard Business School
Boehringer Ingelheim

Generated: April 19, 2018

DrugPatentWatch Database Preview

WYAMINE SULFATE Drug Profile

« Back to Dashboard

Which patents cover Wyamine Sulfate, and what generic alternatives are available?

Wyamine Sulfate is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.

The generic ingredient in WYAMINE SULFATE is mephentermine sulfate. There is one drug master file entry for this compound. Additional details are available on the mephentermine sulfate profile page.
Drug patent expirations by year for WYAMINE SULFATE
Medical Subject Heading (MeSH) Categories for WYAMINE SULFATE
Synonyms for WYAMINE SULFATE
.omega.-Phenyl-tert-butyl-methylamine
(1,1-dimethyl-2-phenylethyl)methylamine
100-92-5
100-92-5 (Parent)
100M925
1212-72-2
1212-72-2 (sulfate (2:1))
2-Methyl-2-methylamino-1-phenylpropane
2-Methylamino-2-methyl-1-phenylpropane
2C11H17N.H2O4S
580655Z8RR
AB00053662
AB00053662_08
AC1L1GGT
AC1L2GHF
AC1NWAW7
AKOS006281398
AKOS030526078
AN-17224
AN-17225
BDBM81455
Benzeneethanamine, N,.alpha.,.alpha.-trimethyl-
Benzeneethanamine, N,alpha,alpha-trimethyl-
Benzeneethanamine, N,alpha,alpha-trimethyl-, sulfate (2:1)
BIS(MEPHENTERMINE); SULFURIC ACID
BPBio1_000718
BRN 1363850
BSPBio_000652
BSPBio_002640
C-55219
C07889
CAS_3677
CAS-1212-72-2
CCG-220726
CCG-39977
CHEBI:6755
CHEBI:6756
CHEMBL1200996
CHEMBL1201234
CHEMBL3184799
D01018
D08180
D0G1OZ
DB01365
DivK1c_000229
DR000178
DSSTox_CID_27760
DSSTox_GSID_47780
DSSTox_RID_82537
DTXSID1047780
DTXSID4023256
EINECS 202-901-6
EINECS 214-923-3
Fentermin
Fentermin (Salt/Mix)
FT-0695148
FT-0751658
GTPL7222
HMS1570A14
HMS1922M15
HMS2092P22
HMS2097A14
HMS2236O06
HMS3369H09
HMS500L11
HSDB 2172
IDI1_000229
KBio1_000229
KBio2_002091
KBio2_004659
KBio2_007227
KBio3_002140
KBioGR_000735
KBioSS_002091
LS-103737
LS-103754
Mefenterdrin
Mefentermin
Mefentermina
Mefentermina [INN-Spanish]
Mephenterdrine
Mephenterdrinum
MEPHENTERMINE
Mephentermine (INN)
Mephentermine (sulfate)
Mephentermine [INN:BAN]
Mephentermine hemisulfate
Mephentermine hemisulfate salt
Mephentermine Hemisulphate
Mephentermine Hemisulphate 1.0 mg/ml in Methanol (as free base)
Mephentermine sodium
Mephentermine sulfate
Mephentermine Sulfate (2:1)
Mephentermine sulfate [USP]
Mephentermine sulphate
Mephenterminum
Mephenterminum [INN-Latin]
Mephetedrine
Mephine
methyl(2-methyl-1-phenylpropan-2-yl)amine
MLS002153976
N-Mephentermine
N-Methyl-.omega.-phenyl-t-butylamine
N-Methyl-.omega.-phenyl-tert-butylamine
N-Methyl-omega-phenyl-t-butylamine
N-Methyl-omega-phenyl-tert-butylamine
N-Methylphentermine
N,.alpha.,.alpha.-Trimethyl-.beta.-phenethylamine
N,.alpha.,.alpha.-Trimethylbenzeneethanamine
N,.alpha.,.alpha.-Trimethylphenethylamine
N,|A,|A-Trimethylphenethylamine hemisulfate salt
N,2-Dimethyl-1-phenyl-2-propanamine #
N,2-dimethyl-1-phenyl-propan-2-amine
N,2-dimethyl-1-phenyl-propan-2-amine; sulfuric acid
N,2-dimethyl-1-phenylpropan-2-amine
N,2-dimethyl-1-phenylpropan-2-amine,sulfuric acid,dihydrate;N,2-dimethyl-1-phenylpropan-2-amine,sulfuric acid,dihydrate
N,2-dimethyl-1-phenylpropan-2-amine; sulfuric acid
N,2-dimethyl-1-phenylpropan-2-amine;N,2-dimethyl-1-phenylpropan-2-amine
N,2-dimethyl-1-phenylpropan-2-amine;sulfuric acid
N,alpha,alpha-Trimethylbenzeneethanamine
N,alpha,alpha-Trimethylphenethylamine
N,alpha,alpha-Trimethylphenethylamine sulfate (2:1)
NCGC00016570-01
NCGC00016570-02
NCGC00016570-03
NCGC00016570-06
NCGC00095030-01
NCGC00095030-02
NINDS_000229
NSC_3677
NSC-758424
NSC758424
O653
omega-Phenyl-tert-butyl-methylamine
OR014286
OR193081
Pharmakon1600-01503250
Phenethylamine, N,.alpha.,.alpha.-trimethyl-
Phenethylamine, N,alpha,alpha-trimethyl-
Phenethylamine, N,alpha,alpha-trimethyl-, sulfate (2:1)
Prestwick_94
Prestwick0_000726
Prestwick1_000726
Prestwick2_000726
Prestwick3_000726
RXQCGGRTAILOIN-UHFFFAOYSA-N
SBB015072
SBI-0051802.P002
SCHEMBL121177
SCHEMBL121178
SCHEMBL6237301
SMR001233313
SPBio_000608
SPBio_002591
Spectrum_001611
SPECTRUM1503250
Spectrum2_000474
Spectrum3_001220
Spectrum4_000188
Spectrum5_001008
SR-05000001843
SR-05000001843-1
ST075547
TEZ91L71V4
Tox21_110501
Tox21_110501_1
UNII-580655Z8RR
UNII-TEZ91L71V4
Vialin
WY-585
Wyamine
Wyamine sulfate (TN)
Wyfentermina
ZINC8132748

US Patents and Regulatory Information for WYAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp WYAMINE SULFATE mephentermine sulfate INJECTABLE;INJECTION 008248-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare Corp WYAMINE SULFATE mephentermine sulfate INJECTABLE;INJECTION 008248-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
McKinsey
Boehringer Ingelheim
QuintilesIMS
Queensland Health
Dow
AstraZeneca
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.